Name	Current Price - Today's Change	Market Cap
CHATTEM INC (CHTT)	$93.50 - $0.18(0.19%)	1.77 B
ABRAXIS BIOSCIENCE NEW (ABII)	$37.50 - $0.90(2.34%)	1.57 B
AUXILIUM PHARMACEUTICALS (AUXL)	$30.87 - $0.04(0.13%)	1.46 B
SALIX PHARMACEUTICALS (SLXP)	$27.27 - $0.17(0.63%)	1.35 B
MEDICIS PHARMA CORP CL A (MRX)	$22.28 - $0.02(0.09%)	1.33 B
MEDIVATION INC (MDVN)	$36.46 - $0.01(0.03%)	1.24 B
WEST PHARMACEUTICAL SVCS (WST)	$36.02 - $0.51(1.44%)	1.19 B
CUBIST PHARMACEUTICALS (CBST)	$20.36 - $0.43(2.16%)	1.17 B
ACORDA THERAPEUTICS INC (ACOR)	$30.22 - $0.30(1.00%)	1.17 B
WUXI PHARMATECH INC ADS (WX)	$15.37 - $0.37(2.35%)	1.10 B

STOCK ANALYSIS

Five Biotechs Worth Follow Up (BLUD, NUVA, SGEN)
Learn how investors can build their own healthcare ETF with a few top-rated stocks.

View All Stock Analysis

BLUD RELATED HEADLINES

The Pomerantz Firm Charges Immucor, Inc. With Securities Fraud -- BLUD
The Pomerantz Firm Charges Immucor, Inc. With Securities Fraud -- BLUD
by GlobeNewswire 10/2/2009

The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Immucor, Inc.
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Immucor, Inc.
by GlobeNewswire 9/15/2009

Immucor (NasdaqNM: BLUD) NewsBite - BLUD Extends Buyback Plan
Immucor (NasdaqNM: BLUD) opened at $17.21. So far today, the stock has hit a low of $17.12 and a high of $17.97. BLUD is now trading at $17.89, up $.79 (4.62%). The stock hit its 52-Week high of $33.80 in October and set its 52-Week low of $11.24 in June. BLUD announced yesterday evening that it would increase its current buyback program by 2 ...
At Market Intelligence Center 8/19/2009

Checking out one of the worst-performing stocks of the calendar year's first half
With the second quarter safely behind us, we decided it was time to select a stock to kick while it's down...(Read More)
By SchaeffersResearch 7/9/2009

Oil Falls As Consumer Confidence Jumps
Consumer spending rose 0.3% during May, while income jumped 1.4%; renewed fears of weak demand pulled oil down 1.5%
Forbes.com 6/26/2009

Immucor (BLUD) NewsBite - BLUD To Lose FDA License for Reagent Product
Immucor (NasdaqNM: BLUD) opened at $11.37. So far today, the stock has hit a low of $11.24 and a high of $13.99. BLUD is now trading at $13.02, down $3.07 (-19.08%). Over the last 52 weeks the stock has ranged from a low of $13.75 to a high of $33.80. BLUD shares are sinking today on news that the FDA will revoke the company's biologics license for its Reagent Red Blood Cells and Anti-E (Monoclo...
At Market Intelligence Center 6/26/2009

View All Headlines